Breaking News
Get 40% Off 0
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas tool Copy Portfolio
Close

Mira Pharmaceuticals Inc (MIRA)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Mira Pharmaceuticals's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.6550 -0.0245    -3.61%
18/05 - Closed. Currency in USD ( Disclaimer )
After Hours
0.6500
-0.0050
-0.76%
06:03:27 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 74,793
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 0.6309 - 0.7100
Mira Pharmaceuticals 0.6550 -0.0245 -3.61%

MIRA Recent Sentiments

 
This page features our users' sentiments regarding the Mira Pharmaceuticals Inc stock. They are displayed on both charts of different time periods and in a detailed table.
BearishBullish
Start Date Username Call Open Rate End Date Chg. %
May 13, 2024 Tania Luis   0.7258 -9.75%
Mar 12, 2024 Sin Sin Chan   1.5800 Apr 05, 2024 @ 1.0200 -35.44%
Mar 08, 2024 Damian Martinez   1.4200 Mar 29, 2024 @ 1.1000 -22.54%
Mar 08, 2024 Petras Kromelis   1.3400 Mar 29, 2024 @ 1.1000 +17.91%
Mar 08, 2024 john harris   1.3300 Mar 29, 2024 @ 1.1000 -17.29%
Mar 08, 2024 רונן בן   1.4200 Mar 29, 2024 @ 1.1000 -22.54%
Mar 08, 2024 חנן דנינו   1.3600 Mar 29, 2024 @ 1.1000 -19.12%
Mar 08, 2024 שירן רפאל   1.6400 Mar 11, 2024 @ 1.6600 +1.22%
Mar 08, 2024 Matteo Iacomucci   1.5500 Mar 11, 2024 @ 1.6600 +7.10%
Mar 07, 2024 André Da Silva   0.9500 Mar 11, 2024 @ 1.6600 +74.74%
Feb 05, 2024 Robbert Kuipers   1.4100 Mar 01, 2024 @ 1.0000 -29.08%
Feb 05, 2024 Robbert Kuipers   1.3400 Feb 05, 2024 @ 1.4100 +5.22%
Feb 05, 2024 Robbert Kuipers   1.1900 Feb 05, 2024 @ 1.3300 +11.76%
Feb 05, 2024 Robbert Kuipers   1.1900 Feb 05, 2024 @ 1.1900 0.00%
Dec 28, 2023 89 World of life   1.1200 Jan 19, 2024 @ 0.8300 -25.89%
Dec 11, 2023 Ziyad Khaled   1.5800 Dec 11, 2023 @ 1.5800 0.00%
Dec 08, 2023 ugur cırak   1.6100 Dec 29, 2023 @ 1.0500 -34.78%
Nov 29, 2023 Taleh Elizade   4.0000 Dec 22, 2023 @ 1.0900 -72.75%
Nov 22, 2023 kermit dekikker   3.2500 Dec 15, 2023 @ 1.3000 +60.00%
Nov 20, 2023 Markos Kebede   4.5200 Dec 15, 2023 @ 1.3000 -71.24%
Nov 20, 2023 Tim Thomas   4.6500 Dec 15, 2023 @ 1.3000 -72.04%
Nov 20, 2023 Arman Kala   5.2500 Dec 15, 2023 @ 1.3000 +75.24%
Nov 20, 2023 יוסף לוי   6.2000 Dec 15, 2023 @ 1.3000 -79.03%
Nov 16, 2023 Pablo Labbate   2.9500 Nov 30, 2023 @ 3.7000 +25.42%
Nov 08, 2023 Robbert Kuipers   1.6800 Dec 01, 2023 @ 3.8000 +126.19%
Oct 12, 2023 Aqeel Shammry   3.0600 Nov 30, 2023 @ 3.7000 -20.92%
Sep 18, 2023 Robbert Kuipers   3.9000 Nov 30, 2023 @ 3.7000 -5.13%
Sep 18, 2023 Robbert Kuipers   3.9000 Sep 18, 2023 @ 3.9000 0.00%
Aug 10, 2023 Tomer Krantz   6.6500 Nov 30, 2023 @ 3.7000 +44.36%
Aug 09, 2023 Sara Luna   6.7500 Nov 30, 2023 @ 3.7000 -45.19%
Aug 04, 2023 Älex Kïñg   6.0100 Nov 30, 2023 @ 3.7000 -38.44%
Aug 04, 2023 Mohamed Ali Sghairi   6.4800 Nov 30, 2023 @ 3.7000 -42.90%
Aug 03, 2023 Şükrü Çetin   6.8800 Nov 30, 2023 @ 3.7000 +46.22%
Aug 03, 2023 Борис Смирнов   7.3500 Nov 30, 2023 @ 3.7000 -49.66%
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MIRA Comments

Write your thoughts about Mira Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email